These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2611484)
1. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of a novel antivasospasm drug, HA1077. Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899 [TBL] [Abstract][Full Text] [Related]
3. Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. Seto M; Sasaki Y; Hidaka H; Sasaki Y Eur J Pharmacol; 1991 Mar; 195(2):267-72. PubMed ID: 1874276 [TBL] [Abstract][Full Text] [Related]
4. Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca2+ level and contraction in vascular smooth muscle. Takizawa S; Hori M; Ozaki H; Karaki H Eur J Pharmacol; 1993 Dec; 250(3):431-7. PubMed ID: 8112403 [TBL] [Abstract][Full Text] [Related]
5. A new type of vasodilator, HA1077, an isoquinoline derivative, inhibits proliferation of bovine vascular smooth muscle cells in culture. Shirotani M; Yui Y; Hattori R; Kawai C J Pharmacol Exp Ther; 1991 Nov; 259(2):738-44. PubMed ID: 1941621 [TBL] [Abstract][Full Text] [Related]
6. Endothelin: a potential modulator of cerebral vasospasm. Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Sugita K; Hidaka H Eur J Pharmacol; 1990 Nov; 190(3):365-72. PubMed ID: 2272374 [TBL] [Abstract][Full Text] [Related]
7. HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery. Nagumo H; Seto M; Sakurada K; Walsh MP; Sasaki Y Eur J Pharmacol; 1998 Nov; 360(2-3):257-64. PubMed ID: 9851593 [TBL] [Abstract][Full Text] [Related]
8. Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm. Satoh S; Suzuki Y; Harada T; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H Eur J Pharmacol; 1992 Sep; 220(2-3):243-8. PubMed ID: 1425995 [TBL] [Abstract][Full Text] [Related]
9. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Honjo M; Inatani M; Kido N; Sawamura T; Yue BY; Honda Y; Tanihara H Arch Ophthalmol; 2001 Aug; 119(8):1171-8. PubMed ID: 11483085 [TBL] [Abstract][Full Text] [Related]
10. The effects of HA1077 on the cerebral circulation after subarachnoid haemorrhage in dogs. Satoh S; Suzuki Y; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H Acta Neurochir (Wien); 1991; 110(3-4):185-8. PubMed ID: 1927613 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs. Nishikibe M; Nagura J; Kamei K; Fukuroda T Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068 [TBL] [Abstract][Full Text] [Related]
12. Vasodilatation produced by fasudil mesylate in vivo and in vitro. Li Q; Chen Y; Sun L; Fu G; Guo L Vascul Pharmacol; 2011; 55(5-6):121-6. PubMed ID: 21763460 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs. III. Nicardipine and isoflurane. Hysing ES; Chelly JE; Doursout MF; Hartley C; Merin RG Anesthesiology; 1986 Oct; 65(4):385-91. PubMed ID: 3767036 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of myosin light chain phosphorylation in cultured smooth muscle cells by HA1077, a new type of vasodilator. Sasaki Y; Sasaki Y Biochem Biophys Res Commun; 1990 Sep; 171(3):1182-7. PubMed ID: 2222437 [TBL] [Abstract][Full Text] [Related]
15. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain. Asano T; Ikegaki I; Satoh S; Mochizuki D; Hidaka H; Suzuki Y; Shibuya M; Sugita K Br J Pharmacol; 1991 Aug; 103(4):1935-8. PubMed ID: 1912980 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs. Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588 [TBL] [Abstract][Full Text] [Related]
17. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077. Seto M; Shindo K; Ito K; Sasaki Y Eur J Pharmacol; 1995 Mar; 276(1-2):27-33. PubMed ID: 7781692 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog. Drieu la Rochelle CD; Grosset A; O'Connor SE Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs. Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]